Poster Presentation
Water's Edge Ballroom (Hilton Waikoloa Village)
Wednesday, July 13, 2005
9:30 AM - 10:00 AM
Water's Edge Ballroom (Hilton Waikoloa Village)
Wednesday, July 13, 2005
2:30 PM - 3:00 PM
This presentation is part of : Poster Presentations
Effects of a 1-Year Internet-Based Diabetic Education Program on Plasma Glucose and Serum Lipids in Women Type 2 Diabetic Patients
Hee-Seung Kim, RN, PhD, School of Nursing, Catholic University, Secho-ku, Seoul, South Korea
Learning Objective #1: Explain how an Internet education can be used as a nursing intervention
Learning Objective #2: Understand that an Internet education would maintain normal range of glycosylated hemoglobin in women type 2 diabetic patients

Purpose: The purpose of this study was to evaluate effects of 1year Internet education on plasma glucose and serum lipids in women type 2 diabetic patients.

Method: Control and experimental groups being assessed pre-test and 3 months, 6 months, 9 months, and 12 months. Fourteen patients were assigned randomly to an intervention group and 15 to a control group. Patients in the intervention group were requested to input their blood glucose levels everyday by cellular phone or wire Internet for 1 year. The goal of the intervention was to keep blood glucose concentrations close to the normal range (glycosylated hemoglobin, HbA1c<7%). The intervention was applied to the intervention group for 1 year weekly. Optimal recommendations were sent weekly by short message service from a cellular phone and wire Internet.

Results: Patients in the intervention group had a significant mean change in HbA1c, from 7.6% at pre-test to 6.9%, at 3 months and rested at 6.7% until 12 months. There was no significant time and group differences were observed in the serum lipids. Patients in the control group had no significant time and group differences were observed in the HbA1c and the serum lipids.

Conclusion: These findings indicated that an Internet education for 1 year would improve and maintain normal range of HbA1c in women type 2 diabetic patients.